A detailed characterization of the adult mouse model of glycogen storage disease Ia

被引:14
作者
Salganik, Susan V. [1 ,2 ]
Weinstein, David A. [3 ]
Shupe, Thomas D. [1 ,2 ]
Salganik, Max [4 ]
Pintilie, Dana G. [1 ,2 ]
Petersen, Bryon E. [1 ,2 ]
机构
[1] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA
[2] Univ Florida, Coll Med, Program Stem Cell Biol & Regenerat Med, Gainesville, FL 32610 USA
[3] Univ Florida, Coll Med, Dept Pediat, Div Pediat Endocrinol, Gainesville, FL 32610 USA
[4] Univ Florida, Coll Med, Powell Gene Therapy Ctr, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA
关键词
Glucose-6-phosphatase; GSD1a mouse model; glycogen storage disease; hypoglycemia; metabolic disorder; MEDIATED GENE-THERAPY; MURINE GLUCOSE-6-PHOSPHATASE; 1A; HYPOGLYCEMIA; MUTATIONS; ADENOMAS; TYPE-1A; CANINE; LIVER; MICE;
D O I
10.1038/labinvest.2009.64
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Glycogen storage disease type Ia (GSDIa) is caused by a genetic defect in the hepatic enzyme glucose-6-phosphatase (G6Pase-alpha), which manifests as life-threatening hypoglycemia with related metabolic complications. A G6Pase-alpha knockout (KO) mouse model was generated to study potential therapies for correcting this disorder. Since then, gene therapy studies have produced promising results, showing long-term improvement in liver histology and glycogen metabolism. Under existing protocols, however, untreated KO pups seldom survived weaning. Here, we present a thorough characterization of the G6Pase-alpha KO mouse, as well as the husbandry protocol for rearing this strain to adulthood. These mice were raised with only palliative care, and characterized from birth through 6 months of age. Once KO mice have survived the very frail weaning period, their size, agility, serum lipids and glycemic control improve dramatically, reaching levels approaching their wild-type littermates. In addition, our data reveal that adult mice lacking G6Pase-alpha are able to mate and produce viable offspring. However, liver histology and glycogen accumulation do not improve with age. Overall, the reliable production of mature KO mice could provide a critical tool for advancing the GSDIa field, as the availability of a robust enzyme-deficient adult offers a new spectrum of treatment avenues that would not be tolerated by the frail pups. Most importantly, our detailed characterization of the adult KO mouse provides a crucial baseline for accurately gauging the efficacy of experimental therapies in this important model. Laboratory Investigation (2009) 89, 1032-1042; doi:10.1038/labinvest.2009.64; published online 6 July 2009
引用
收藏
页码:1032 / 1042
页数:11
相关论文
共 50 条
  • [31] Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia
    Koeberl, D. D.
    Sun, B. D.
    Damodaran, T. V.
    Brown, T.
    Millington, D. S.
    Benjamin, D. J., Jr.
    Bird, A.
    Schneider, A.
    Hillman, S.
    Jackson, M.
    Beaty, R. M.
    Chen, Y. T.
    GENE THERAPY, 2006, 13 (17) : 1281 - 1289
  • [32] Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia
    D D Koeberl
    B D Sun
    T V Damodaran
    T Brown
    D S Millington
    D K Benjamin
    A Bird
    A Schneider
    S Hillman
    M Jackson
    R M Beaty
    Y T Chen
    Gene Therapy, 2006, 13 : 1281 - 1289
  • [33] Persistent hypoglycemia Glycogen storage disease type Ib
    Rabener, Michael J.
    Howell, Christopher M.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2020, 33 (04): : 1 - 3
  • [34] Glycogen storage disease in two sisters: A case report
    Twanabasu, Sajal
    Duwadee, Prabin
    Homagain, Sushan
    Ghimire, Jeevan
    Rijal, Ram Chandra
    CLINICAL CASE REPORTS, 2023, 11 (05):
  • [35] Increased levels of hemostatic proteins are independent of inflammation in glycogen storage disease type Ia
    Marfaing-Koka, A
    Wolf, M
    Boyer-Neumann, C
    Meyer, D
    Odievre, T
    Labrune, T
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2003, 37 (05) : 566 - 570
  • [36] MR imaging of the liver and complicating hepatic tumors in type Ia glycogen storage disease
    Hirota S.
    Sugimoto K.
    Matsumoto S.
    Kono M.
    Harada Y.
    International Journal of Clinical Oncology, 1997, 2 (1) : 1 - 5
  • [37] Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy
    Brooks, Elizabeth D.
    Landau, Dustin J.
    Everitt, Jeffrey I.
    Brown, Talmage T.
    Grady, Kylie M.
    Waskowicz, Lauren
    Bass, Cameron R.
    D'Angelo, John
    Asfaw, Yohannes G.
    Williams, Kyha
    Kishnani, Priya S.
    Koeberl, Dwight D.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2018, 41 (06) : 965 - 976
  • [38] Perioperative management of benign hepatic tumors in patients with glycogen storage disease type Ia
    Oshita, Akihiko
    Itamoto, Toshiyuki
    Amano, Hironobu
    Ohdan, Hideki
    Tashiro, Hirotaka
    Asahara, Toshimasa
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 2008, 15 (02): : 200 - 203
  • [39] Acute pancreatitis after anesthesia with propofol in a child with glycogen storage disease type IA
    Bustamante, Sergio E.
    Appachi, Elumalai
    PEDIATRIC ANESTHESIA, 2006, 16 (06) : 680 - 683
  • [40] Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs
    Derks, Terry G. J.
    Rodriguez-Buritica, David F.
    Ahmad, Ayesha
    de Boer, Foekje
    Couce, Maria L.
    Gruenert, Sarah C.
    Labrune, Philippe
    Lopez Maldonado, Nerea
    Fischinger Moura de Souza, Carolina
    Riba-Wolman, Rebecca
    Rossi, Alessandro
    Saavedra, Heather
    Gupta, Rupal Naik
    Valayannopoulos, Vassili
    Mitchell, John
    NUTRIENTS, 2021, 13 (11)